Advertisement
Letter to the Editor| Volume 19, ISSUE 11, P1029, November 2018

Potentially Inappropriate Medications and Polypharmacy

      One cross-sectional study conducted by Anrys and colleagues
      • Anrys P.M.S.
      • Strauven G.C.
      • Foulon V.
      • et al.
      Potentially inappropriate prescribing in Belgian nursing homes: Prevalence and associated factors.
      published in JAMDA has reported that the prevalence of potentially inappropriate medications was 88.3% among nursing home residents aged ≥65 years. The definition of potentially inappropriate medications is the use of a drug where a clinical indication does not exist or the use of an indicated drug in conditions where the risk outweighs the benefit.
      • Moriarty F.
      • Bennett K.
      • Fahey T.
      • et al.
      Longitudinal prevalence of potentially inappropriate medicines and potential prescribing omissions in a cohort of community-dwelling older people.
      Anrys and colleagues also reported that polypharmacy (use of 5 or more drugs) was significantly associated with potentially inappropriate medications.
      • Anrys P.M.S.
      • Strauven G.C.
      • Foulon V.
      • et al.
      Potentially inappropriate prescribing in Belgian nursing homes: Prevalence and associated factors.
      Polypharmacy in older people has been found to be associated with increased risk of morbidities and mortalities.
      • Lai S.W.
      • Liao K.F.
      • Liao C.C.
      • et al.
      Polypharmacy correlates with increased risk for hip fracture in the elderly: A population-based study.
      • Saum K.U.
      • Schottker B.
      • Meid A.D.
      • et al.
      Is polypharmacy associated with frailty in older people? Results from the ESTHER cohort study.
      • Schoufour J.D.
      • Oppewal A.
      • van der Maarl H.J.K.
      • et al.
      Multimorbidity and polypharmacy are independently associated with mortality in older people with intellectual disabilities: A 5-year follow-up from the HA-ID study.
      To date, there is no definite cutoff number for defining polypharmacy. According to Masnoon and colleagues' review, the use of 5 or more drugs daily is the most commonly reported definition for polypharmacy in older people.
      • Masnoon N.
      • Shakib S.
      • Kalisch-Ellett L.
      • et al.
      What is polypharmacy? A systematic review of definitions.
      Anrys and colleagues emphasize that interventions for potentially inappropriate medications should target older people taking at least 10 drugs. In order to reduce polypharmacy and potentially inappropriate medications in older people, clinicians should review the indications for drugs prescribed among those people taking 5 or more drugs during every clinical visit. If the indication does not exist, this drug should not be prescribed again. Therefore, medication safety in older people can be improved.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Anrys P.M.S.
        • Strauven G.C.
        • Foulon V.
        • et al.
        Potentially inappropriate prescribing in Belgian nursing homes: Prevalence and associated factors.
        J Am Med Dir Assoc. 2018; 19: 884-890
        • Moriarty F.
        • Bennett K.
        • Fahey T.
        • et al.
        Longitudinal prevalence of potentially inappropriate medicines and potential prescribing omissions in a cohort of community-dwelling older people.
        Eur J Clin Pharmacol. 2015; 71: 473-482
        • Lai S.W.
        • Liao K.F.
        • Liao C.C.
        • et al.
        Polypharmacy correlates with increased risk for hip fracture in the elderly: A population-based study.
        Medicine (Baltimore). 2010; 89: 295-299
        • Saum K.U.
        • Schottker B.
        • Meid A.D.
        • et al.
        Is polypharmacy associated with frailty in older people? Results from the ESTHER cohort study.
        J Am Geriatr Soc. 2017; 65: e27-e32
        • Schoufour J.D.
        • Oppewal A.
        • van der Maarl H.J.K.
        • et al.
        Multimorbidity and polypharmacy are independently associated with mortality in older people with intellectual disabilities: A 5-year follow-up from the HA-ID study.
        Am J Intellect Dev Disabil. 2018; 123: 72-82
        • Masnoon N.
        • Shakib S.
        • Kalisch-Ellett L.
        • et al.
        What is polypharmacy? A systematic review of definitions.
        BMC Geriatr. 2017; 17: 230